---
layout: post
title: "Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Polyvalent Vaccines and Methods for Making Them"
date: 2026-02-05 19:09:13 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-08361
original_published: 2024-04-19 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Polyvalent Vaccines and Methods for Making Them

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 19, 2024 00:00 UTC
**Document Number:** 2024-08361

## Summary

The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, on behalf of the Centers for Disease Control and Prevention, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to University Health Network, located in Toronto, Canada, its rights to the technologies and the patent applications listed in the SUPPLEMENTARY INFORMATION section of this notice.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/04/19/2024-08361/prospective-grant-of-exclusive-license-inter-institutional-agreement-institution-lead-polyvalent)
- API: https://www.federalregister.gov/api/v1/documents/2024-08361

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
